Literature DB >> 29704001

Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness.

Andy C Dean1,2, Angelica M Morales3, Gerhard Hellemann3, Edythe D London3,4,5.   

Abstract

Individuals with cognitive problems may be predisposed to develop substance use disorders; therefore, differences in cognitive function between methamphetamine users and control participants may be attributable to premorbid factors rather than methamphetamine use. The goal of this study was to clarify the extent to which this is the case. Childhood academic transcripts were obtained for 37 methamphetamine-dependent adults and 41 control participants of similar educational level and premorbid IQ. Each participant completed a comprehensive cognitive battery and received a structural magnetic resonance imaging scan. Data from control participants and linear regression were used to develop a normative model to describe the relationship between childhood academic performance and scores on the cognitive battery. Using this model, cognitive performance of methamphetamine users was predicted from their premorbid academic scores. Results indicated that methamphetamine users' childhood grade point average was significantly lower than that of the control group (p < 0.05). Further, methamphetamine users' overall cognitive performance was lower than was predicted from their grade point average prior to methamphetamine use (p = 0.001), with specific deficits in attention/concentration and memory (ps < 0.01). Memory deficits were associated with lower whole-brain cortical thickness (p < 0.05). Thus, in addition to having an apparent premorbid weakness in cognition, methamphetamine users exhibit subsequent cognitive function that is significantly lower than premorbid estimates would predict. The results support the view that chronic methamphetamine use causes a decline in cognition and/or a failure to develop normative cognitive abilities, although aside from methamphetamine use per se, other drug use and unidentified factors likely contribute to the observed effects.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29704001      PMCID: PMC6006320          DOI: 10.1038/s41386-018-0065-1

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  36 in total

1.  Spatial working memory as an endophenotype for schizophrenia.

Authors:  David C Glahn; Sebastian Therman; Marko Manninen; Matti Huttunen; Joakko Kaprio; Jouko Lönnqvist; Tyrone D Cannon
Journal:  Biol Psychiatry       Date:  2003-04-01       Impact factor: 13.382

Review 2.  What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?

Authors:  Maria Jose Fernández-Serrano; Miguel Pérez-García; Antonio Verdejo-García
Journal:  Neurosci Biobehav Rev       Date:  2010-05-06       Impact factor: 8.989

3.  Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder.

Authors:  Ralph E Tarter; Levent Kirisci; Ada Mezzich; Jack R Cornelius; Kathleen Pajer; Michael Vanyukov; William Gardner; Timothy Blackson; Duncan Clark
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

4.  Premorbid clues? Preinjury scholastic performance and present neuropsychological functioning in late postconcussion syndrome.

Authors:  M Frank Greiffenstein; W John Baker
Journal:  Clin Neuropsychol       Date:  2003-11       Impact factor: 3.535

5.  Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.

Authors:  Chelsea L Robertson; Kenji Ishibashi; Mark A Mandelkern; Amira K Brown; Dara G Ghahremani; Fred Sabb; Robert Bilder; Tyrone Cannon; Jacqueline Borg; Edythe D London
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 6.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

7.  Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers.

Authors:  Seog Ju Kim; In Kyoon Lyoo; Jaeuk Hwang; Ain Chung; Young Hoon Sung; Jihyun Kim; Do-Hoon Kwon; Kee Hyun Chang; Perry F Renshaw
Journal:  Int J Neuropsychopharmacol       Date:  2005-06-28       Impact factor: 5.176

8.  Psychometric evaluation of the Amphetamine Cessation Symptom Assessment.

Authors:  Catherine McGregor; Manit Srisurapanont; Amanda Mitchell; Marie C Longo; Sharon Cahill; Jason M White
Journal:  J Subst Abuse Treat       Date:  2007-07-13

Review 9.  An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Authors:  Andy C Dean; Stephanie M Groman; Angelica M Morales; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853

10.  Abnormal brain structure implicated in stimulant drug addiction.

Authors:  Karen D Ersche; P Simon Jones; Guy B Williams; Abigail J Turton; Trevor W Robbins; Edward T Bullmore
Journal:  Science       Date:  2012-02-03       Impact factor: 47.728

View more
  10 in total

1.  Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.

Authors:  Aaron C Lim; Erica N Grodin; Rejoyce Green; Alexandra Venegas; Lindsay R Meredith; Kelly E Courtney; Nathasha R Moallem; Philip Sayegh; Edythe D London; Lara A Ray
Journal:  Am J Drug Alcohol Abuse       Date:  2020-04-28       Impact factor: 3.829

2.  Cortical thickness and related depressive symptoms in early abstinence from chronic methamphetamine use.

Authors:  Johannes Petzold; Andy C Dean; Jean-Baptiste Pochon; Dara G Ghahremani; Richard De La Garza; Edythe D London
Journal:  Addict Biol       Date:  2022-09       Impact factor: 4.093

3.  Cognition during active methamphetamine use versus remission.

Authors:  Marilyn Huckans; Stephen Boyd; Grant Moncrief; Nathan Hantke; Bethany Winters; Kate Shirley; Emily Sano; Holly McCready; Laura Dennis; Milky Kohno; William Hoffman; Jennifer M Loftis
Journal:  J Clin Exp Neuropsychol       Date:  2021-10-06       Impact factor: 2.283

4.  Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.

Authors:  Mariana Cherner; Caitlin W-M Watson; Rowan Saloner; Laura E Halpin; Arpi Minassian; Sarah S Murray; Florin Vaida; Chad Bousman; Ian Everall
Journal:  Addict Behav       Date:  2019-06-12       Impact factor: 4.591

5.  Brain Structure Alterations in Poly-Drug Use: Reduced Cortical Thickness and White Matter Impairments in Regions Associated With Affective, Cognitive, and Motor Functions.

Authors:  Human F Unterrainer; Michaela Hiebler-Ragger; Karl Koschutnig; Jürgen Fuchshuber; Klemens Ragger; Corinna M Perchtold; Ilona Papousek; Elisabeth M Weiss; Andreas Fink
Journal:  Front Psychiatry       Date:  2019-09-20       Impact factor: 4.157

6.  Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder.

Authors:  Milky Kohno; Angelica M Morales; Laura E Dennis; Holly McCready; William F Hoffman; P Todd Korthuis
Journal:  Front Psychiatry       Date:  2019-09-03       Impact factor: 4.157

Review 7.  Cognition and addiction
.

Authors:  Antonio Verdejo-Garcia; Gloria Garcia-Fernandez; Geert Dom
Journal:  Dialogues Clin Neurosci       Date:  2019-09       Impact factor: 5.986

8.  Age Influences Loss Aversion Through Effects on Posterior Cingulate Cortical Thickness.

Authors:  Zoe R Guttman; Dara G Ghahremani; Jean-Baptiste Pochon; Andy C Dean; Edythe D London
Journal:  Front Neurosci       Date:  2021-07-12       Impact factor: 4.677

9.  CYP2D6 genotype may moderate measures of brain structure in methamphetamine users.

Authors:  Andy C Dean; Erika L Nurmi; Angelica M Morales; Arthur K Cho; Lauren C Seaman; Edythe D London
Journal:  Addict Biol       Date:  2020-08-06       Impact factor: 4.093

10.  qEEG Measures of Attentional and Memory Network Functions in Medical Students: Novel Targets for Pharmacopuncture to Improve Cognition and Academic Performance.

Authors:  Vasavi R Gorantla; Vernon Bond; James Dorsey; Sarah Tedesco; Tanisha Kaur; Matthew Simpson; Sudhakar Pemminati; Richard M Millis
Journal:  J Pharmacopuncture       Date:  2019-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.